Do regular oral antibiotics prevent hospital admission for patients with moderate to severe chronic obstructive pulmonary disease (COPD)?

ISRCTN ISRCTN97227471
DOI https://doi.org/10.1186/ISRCTN97227471
Secondary identifying numbers N0333119989
Submission date
12/09/2003
Registration date
12/09/2003
Last edited
14/03/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Phil Ryan
Scientific

Consultant Oncologist
The County Hospital
Union Walk
Hereford
HR1 2ER
United Kingdom

Study information

Study designBlinded randomised placebo controlled intervention
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeNot Specified
Scientific title
Study objectivesTo find out whether taking a regular oral antibiotics prevents hospital admission for patients with moderate to severe COPD?
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedRespiratory: Chronic obstructive pulmonary disease (COPD)
InterventionBlinded randomised placebo controlled intervention study using oral antiobiotics (amoxycillin) regularly. From November 2003 to March 2004 recruiting COPD patients.
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)amoxycillin
Primary outcome measureResearching a clinical problem which is common and also has a large impact upon acute medical admissions
Secondary outcome measuresNot provided at time of registration
Overall study start date20/12/2002
Completion date20/12/2006

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participantsNot provided at time of registration
Key inclusion criteriaPatients from medical admissions and the Out Patient Department.
Key exclusion criteriaNot provided at time of registration
Date of first enrolment20/12/2002
Date of final enrolment20/12/2006

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Consultant Oncologist
Hereford
HR1 2ER
United Kingdom

Sponsor information

Department of Health (UK)
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Website http://www.doh.gov.uk

Funders

Funder type

Government

Hereford Hospitals NHS Trust (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan